Cancer Imaging Program Fellowship

Exciting new updates to this world-class Cancer Imaging fellowship

Accepting applications for July 2027!

The Cancer Imaging Program (CIP) Fellowship at Beth Israel Deaconess Medical Center (BIDMC) and Dana-Farber Cancer Institute (DFCI) provides a comprehensive education in body imaging (chest and abdomen), including MRI, CT, PET-CT, and US, with an emphasis on adult patients with cancer. Dana-Farber Cancer Institute is a world-renowned cancer center, Harvard Medical School teaching affiliate, and provides subspecialty adult clinical care jointly with Beth Israel Deaconess Medical Center. 

Clinical Experience

The CIP Fellowship provides a comprehensive experience in body imaging, with fellows’ time divided between thoracic and abdominal subspecialties throughout the year. Fellows receive one-on-one, onsite training from jointly appointed, subspecialized BIDMC/DFCI faculty across multiple imaging modalities including CT, MRI, and ultrasound.

• The MRI curriculum focuses on advanced cancer-related abdomen and pelvis applications (1.5T and 3T systems) including prostate, rectal, hepatobiliary, female pelvis, and MR urography, among others.
• Interpreting and protocoling initial cancer staging CT scans and oncologic follow-ups are the focus of the thoracic and abdominal CT experiences.
• Ultrasound assignments cover routine abdominal, male and female pelvic/genitourinary, thyroid, basic vascular (DVT), and superficial soft tissue exams.
• Additional experience in reading inpatient and general CT and MRI examinations is also available throughout the workday and on-call, making the CIP fellowship a comprehensive body imaging experience.
• Clinical coverage responsibility for fellows includes weekday and weekend clinical coverage at the DFCI and BIDMC Longwood campuses and rotating weekday coverage at the Dana-Farber Chestnut Hill campus.

Teaching/Conferences

In addition to continual one-on-one teaching throughout the day, ample protected time for formal didactics includes:

• Weekly CIP seminar series (designated for Category 1 CME credit) covering comprehensive topics in cancer imaging.
• Multidisciplinary tumor boards (e.g. Colorectal, Hepatobiliary, Prostate)
• Daily thoracic and abdominal subspecialty case-based conferences
• MRI/physics lectures
• Extensive database of pre-recorded lectures to supplement learning

In addition, fellows have the opportunity to develop their own teaching skills through participation in resident lectures and reading room education.

Research Experience

Dedicated research time is available for fellows submitting approved research projects in conjunction with an attending radiologist as project mentor. Research time may begin two months after the start of the fellowship and is contingent on clinical coverage and project approval by the Fellowship Program Director. Assistance in identifying projects and research mentors can be provided as necessary. Research milestone schedules are clearly articulated at the start of the project and research progress is monitored on a continuous basis throughout the year.

Elective Time

Up to four weeks of the CIP Fellowship may be used as elective time which may be spent in other radiology disciplines within BIDMC or as additional time for approved research. Meeting time can also be granted for accepted research.

PET-CT Clinical Rotation

This optional clinical rotation will provide physicians with advanced clinical imaging training in oncology with a focus on PET-CT, molecular imaging, evaluation of novel therapeutic drugs, and new PET radiopharmaceuticals.

Eligibility

U.S. applicants must be board-eligible or board-certified in radiology. Foreign applicants must be ECFMG certified and eligible to obtain a clinical visa prior to starting the fellowship. The fellowship at Dana-Farber is structured in accordance with fellowship regulations as provided by the Department of Radiology at Beth Isreal Deaconess Medical Center.

Application Process

Applicants can send a completed PDF application along with their C.V., personal statement, letter of recommendation from your program director or current director, two additional letters of recommendation,  USMLE scores to CancerImagingFellowship@dfci.harvard.edu . Canadian Physicians and Doctors of Osteopathy who are eligible may substitute documents: LMCC/MCCQE and COMLEX examinations. Other foreign applicants must send ECFMG certification. Applicants selected for interviews will be contacted individually.

We are committed to the fairness, and consistency of the recruiting process and will adhere to the 2026 SCARD embargo guidelines. All interviews will be conducted virtually. We will start accepting applications for the 2027-2028 CIP Fellowship on November 1, 2025. Interviews will start no earlier January 12, 2026. Exceptions to this embargo include international candidates, internal candidates, military candidates, and applicants whose spouse/domestic partner is also applying for fellowship in the same year.

SCARD fellowship guidelines

We are an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability status, protected veteran status, or any other characteristic protected by law.

Contact

Abraham Fourie Bezuidenhout, Cancer Imaging Fellowship Program Director
Dana-Farber Cancer Institute, Department of Imaging (DL101)
450 Brookline Avenue
Boston, MA 02215
Attention: Ashley Watterson

Phone: 617-632-4891
Fax: 617-582-8574
Email: CancerImagingFellowship@dfci.harvard.edu

About Dana-Farber Cancer Institute

Connections working at Dana-Farber Cancer Institute